Reimagining Post-COVID-19 Continuity of Care for Bipolar Disorder: Nursing Strategies to Address Trauma and Chronic Stress.

Reimagining Post-COVID-19 Continuity of Care for Bipolar Disorder: Nursing Strategies to Address Trauma and Chronic Stress.

Publication date: Sep 02, 2025

According to a recent WHO survey, approximately 93% of countries reported disruptions in mental healthcare provision in the post-COVID-19 era. These have had a significant impact on individuals living with bipolar disorder (BD), many of whom have encountered substantial barriers to accessing mental health services and pharmacological treatment. These factors have been associated with an increased relapse risk, heightened psychosocial stress, and impaired daily functioning. Emerging research underscores the need for interventions that address the chronic stressors experienced by individuals with BD, particularly in the wake of the global trauma induced by the pandemic. In this context, nursing-led interventions play a crucial role, not only in supporting individuals with BD, but also in engaging families and informal caregivers. These interventions emphasize proactive therapeutic engagement, education on relapse signs, and development of adaptive coping strategies. All these contribute to sustained recovery and improved quality of care. This perspective paper explored the challenges and opportunities in delivering mental healthcare to individuals with BD in the post-pandemic era and outlined targeted, nursing-driven approaches that respond to the long-term mental health burden of trauma and chronic stress.

Open Access PDF

Concepts Keywords
Global bipolar disorder
Nursing carers
Pharmacological chronic stress
Relapse continuity of care
families
informal caregivers
intervention
mental health
nursing
post-COVID

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Bipolar Disorder
disease MESH relapse
disease IDO role
disease IDO quality
disease MESH Long Covid
drug DRUGBANK Coenzyme M
disease IDO intervention
drug DRUGBANK Trestolone
disease MESH emotional distress
disease MESH psychological well being
disease MESH psychosocial functioning
drug DRUGBANK Aspartame
drug DRUGBANK Methionine
disease MESH burnout
disease IDO symptom
disease MESH psychosis
drug DRUGBANK Clozapine
disease MESH uncertainty
disease MESH mental illness
disease MESH mood disorder
disease MESH schizophrenia
disease MESH Depression
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Carboxyamidotriazole
disease MESH Suicidal Ideation
disease MESH Lifestyle

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *